Laura Liberman

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Imaging-histologic discordance at percutaneous breast biopsy
    L Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 89:2538-46. 2000
  2. ncbi Fast MRI-guided vacuum-assisted breast biopsy: initial experience
    Laura Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 181:1283-93. 2003
  3. ncbi MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience
    Laura Liberman
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 185:183-93. 2005
  4. ncbi Percutaneous image-guided core breast biopsy
    Laura Liberman
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiol Clin North Am 40:483-500, vi. 2002
  5. ncbi Breast imaging reporting and data system (BI-RADS)
    Laura Liberman
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Radiol Clin North Am 40:409-30, v. 2002
  6. ncbi Carcinoma detection at the breast examination center of Harlem
    Laura Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 95:8-14. 2002
  7. ncbi Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size
    Laura Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 186:426-30. 2006
  8. ncbi Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy
    Laura Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 188:684-90. 2007
  9. ncbi Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy?
    Laura Liberman
    Breast Imaging Research Programs, Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 186:1328-34. 2006
  10. ncbi Breast MR imaging in assessing extent of disease
    Laura Liberman
    Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Magn Reson Imaging Clin N Am 14:339-49, vi. 2006

Collaborators

Detail Information

Publications52

  1. ncbi Imaging-histologic discordance at percutaneous breast biopsy
    L Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 89:2538-46. 2000
    ..The purpose of the current study was to determine the frequency of imaging-histologic discordance at percutaneous breast biopsy and to assess the likelihood of carcinoma in these discordant lesions...
  2. ncbi Fast MRI-guided vacuum-assisted breast biopsy: initial experience
    Laura Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 181:1283-93. 2003
    ..MRI-guided biopsy was performed with a vacuum-assisted probe, followed by placement of a localizing clip, and then needle localization for surgical excision. Vacuum-assisted biopsy and surgical histology were correlated...
  3. ncbi MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience
    Laura Liberman
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 185:183-93. 2005
    ..The objective of this study was to evaluate our initial clinical experience with MRI-guided vacuum-assisted breast biopsy as an alternative to surgical excision...
  4. ncbi Percutaneous image-guided core breast biopsy
    Laura Liberman
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiol Clin North Am 40:483-500, vi. 2002
    ..This article reviews advantages, limitations, controversies, and future directions in percutaneous image-guided core breast biopsy...
  5. ncbi Breast imaging reporting and data system (BI-RADS)
    Laura Liberman
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Radiol Clin North Am 40:409-30, v. 2002
    ..Although the lexicon is clinically useful and facilitates communication and research, there is still substantial interobserver variability in its application. Lexicons for breast sonography and breast MRI are in progress...
  6. ncbi Carcinoma detection at the breast examination center of Harlem
    Laura Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 95:8-14. 2002
    ..This study reports the results of a breast carcinoma screening and diagnostic program in Harlem...
  7. ncbi Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size
    Laura Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 186:426-30. 2006
    ..The purpose of this study was to determine the impact of lesion size on the positive predictive value (PPV) of biopsy in MRI-detected breast lesions...
  8. ncbi Underestimation of atypical ductal hyperplasia at MRI-guided 9-gauge vacuum-assisted breast biopsy
    Laura Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 188:684-90. 2007
    ....
  9. ncbi Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy?
    Laura Liberman
    Breast Imaging Research Programs, Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 186:1328-34. 2006
    ..The study objective was to determine the cancer frequency in lesions yielding a benign, concordant diagnosis of papilloma at percutaneous breast biopsy...
  10. ncbi Breast MR imaging in assessing extent of disease
    Laura Liberman
    Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Magn Reson Imaging Clin N Am 14:339-49, vi. 2006
    ..If breast MR imaging is used in evaluating extent of disease, it is necessary to have the capability to perform biopsy of lesions detected by MR imaging only...
  11. ncbi Probably benign lesions at breast magnetic resonance imaging: preliminary experience in high-risk women
    Laura Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 98:377-88. 2003
    ..The purpose of the current study was to determine the frequency of 'probably benign' interpretations at breast magnetic resonance (MR) imaging screening of high-risk women and the frequency of subsequent malignancy in these women...
  12. ncbi Imaging breast cancer
    Lia Bartella
    Department of Radiology, Breast Imaging Section H 118, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Radiol Clin North Am 45:45-67. 2007
    ..Advances in this field are having a great impact in the clinical management of this disease. Breast cancer has now become an "outpatient cancer". This article describes the role and advances of imaging in breast cancer...
  13. ncbi MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer
    Laura Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 180:901-10. 2003
    ..The yield was highest in women with a family history of breast cancer or infiltrating lobular histology in the index cancer. Change after biopsy was infrequent and did not interfere with the MR imaging interpretation...
  14. ncbi Breast lesions detected on MR imaging: features and positive predictive value
    Laura Liberman
    Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 179:171-8. 2002
    ..Final assessment categories were significant predictors of carcinoma...
  15. ncbi To excise or to sample the mammographic target: what is the goal of stereotactic 11-gauge vacuum-assisted breast biopsy?
    Laura Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 179:679-83. 2002
    ..This study was undertaken to determine whether complete percutaneous excision rather than sampling of the mammographic target conveys any significant advantage or disadvantage at stereotactic 11-gauge vacuum-assisted biopsy...
  16. ncbi Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study
    Sunitha B Thakur
    Departments of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Magn Reson Imaging 33:855-63. 2011
    ..Reference standard was histology...
  17. ncbi Imaging histologic discordance at MRI-guided 9-gauge vacuum-assisted breast biopsy
    Jung Min Lee
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 189:852-9. 2007
    ..The purpose of this study was to determine the frequency of discordance at MRI-guided vacuum-assisted biopsy and to assess the cancer rate in discordant lesions...
  18. ncbi Outcomes for women with ductal carcinoma-in-situ and a positive sentinel node: a multi-institutional audit
    Katrina H Moore
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Ave, MRI 1026, New York, NY 10021, USA
    Ann Surg Oncol 14:2911-7. 2007
    ..Although it is well established that nodal status for invasive disease is prognostically important, the clinical relevance of a positive SLN in patients with DCIS remains undetermined...
  19. ncbi Ductal enhancement on MR imaging of the breast
    Laura Liberman
    Breast Imaging Section, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 181:519-25. 2003
    ..The purpose of this study was to determine the prevalence and positive predictive value of ductal enhancement among MR imaging-detected breast lesions that had biopsy and to assess the histologic findings associated with ductal enhancement...
  20. ncbi Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy?
    Sarah A McLaughlin
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Cancer 112:1214-21. 2008
    ..In the current study, recent experience with PM was described and the value of preoperative magnetic resonance imaging (MRI) was analyzed in selecting patients for PM with or without SLNB...
  21. ncbi Complete excision of the MRI target lesion at MRI-guided vacuum-assisted biopsy of breast cancer
    Jung Min Lee
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    AJR Am J Roentgenol 191:1198-202. 2008
    ..The purpose of our study was to determine the frequency of complete removal of the imaging target at MRI-guided vacuum-assisted biopsy of breast cancer and to assess the residual cancer rate at surgery in these lesions...
  22. ncbi MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer
    Laura Liberman
    Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    AJR Am J Roentgenol 180:333-41. 2003
    ..Cancer was found in 20% of women who underwent contralateral breast biopsy and in 5% of women who underwent contralateral breast MR imaging...
  23. ncbi Histologic heterogeneity of masses at percutaneous breast biopsy
    Elizabeth A Morris
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Breast J 8:187-91. 2002
    ..Our data suggest that sampling part but not all of a mass may miss certain histologic components of the mass, but should not result in a failure to diagnose carcinoma...
  24. ncbi Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging
    Jennifer H Menell
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Breast J 11:382-90. 2005
    ..In this study, MRI was significantly more sensitive than mammography in DCIS detection. In women with known or suspected DCIS, MRI may have an important role to play in assessing the extent of disease in the breast...
  25. ncbi Papilloma diagnosed at MRI-guided vacuum-assisted breast biopsy: is surgical excision still warranted?
    Sandra B Brennan
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 199:W512-9. 2012
    ..The objective of our study was to determine the frequency of cancer at surgery in breast lesions yielding papilloma at MRI-guided 9-gauge vacuum-assisted biopsy (VAB) and to determine whether any features are associated with cancer upgrade...
  26. ncbi Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy
    Lia Bartella
    Department of Radiology, Breast Imaging Section H 118, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 245:80-7. 2007
    ....
  27. ncbi MRI of occult breast carcinoma in a high-risk population
    Elizabeth A Morris
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 181:619-26. 2003
    ..The purpose of this study was to determine the frequency of cancer and the positive predictive value of biopsy in the first screening round of breast MRI in women at high risk of developing breast cancer...
  28. ncbi Breast lesions detected with MR imaging: utility and histopathologic importance of identification with US
    Linda R LaTrenta
    Department of Radiology, Memorial Sloan Kettering Guttman Diagnostic Center, 55 Fifth Ave, 12th Floor, New York, NY 10003, USA
    Radiology 227:856-61. 2003
    ..To determine the utility and histopathologic importance of ultrasonographic (US) depiction of breast lesions detected with magnetic resonance (MR) imaging...
  29. ncbi MRI identifies otherwise occult disease in select patients with Paget disease of the nipple
    Mary Morrogh
    Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Am Coll Surg 206:316-21. 2008
    ..The purpose of this study was to evaluate the role of breast MRI in this setting...
  30. ncbi Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up
    Niamh M Hambly
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    AJR Am J Roentgenol 196:218-24. 2011
    ..The aim of this study was to determine the effect of background parenchymal enhancement on short-interval follow-up, biopsy, and cancer detection rate on baseline screening MRI in a high-risk group...
  31. ncbi Underestimation of DCIS at MRI-guided vacuum-assisted breast biopsy
    Jung Min Lee
    Breast Imaging Section, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 189:468-74. 2007
    ..The study objective was to assess the rate of underestimation of ductal carcinoma in situ (DCIS) at MRI-guided 9-gauge vacuum-assisted breast biopsy...
  32. ncbi Preoperative MR imaging-guided needle localization of breast lesions
    Elizabeth A Morris
    Breast Imaging Section, Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 178:1211-20. 2002
    ..The positive predictive value of MR imaging-guided needle localization (30.7%) was comparable to that reported for mammographically guided needle localization and was highest in women with synchronous breast cancer...
  33. ncbi One operation after percutaneous diagnosis of nonpalpable breast cancer: frequency and associated factors
    Laura Liberman
    Department of Radiology, Breast Imaging Section, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 178:673-9. 2002
    ..5% of women who had mastectomy. Among women who had breast conservation, one operation was significantly more likely if histologic underestimation was absent or if a mammographic mass was present...
  34. ncbi MRI screening in a clinic population with a family history of breast cancer
    Jeanne Yu
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Surg Oncol 15:452-61. 2008
    ..We describe our experience with MRI screening in a large population of women with a family history of breast cancer...
  35. ncbi The predictive value of ductography and magnetic resonance imaging in the management of nipple discharge
    Mary Morrogh
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Ann Surg Oncol 14:3369-77. 2007
    ..The aim of this study was to determine the predictive value of ductography (DG) and magnetic resonance imaging (MRI) in this setting...
  36. ncbi Nonpalpable mammographically occult invasive breast cancers detected by MRI
    Lia Bartella
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, H118, 1275 York Ave, New York, NY 10021, USA
    AJR Am J Roentgenol 186:865-70. 2006
    ..The purpose of this study was to determine the MRI findings and histology of clinically and mammographically occult invasive breast cancers detected by MRI...
  37. ncbi Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study
    Lia Bartella
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
    Radiology 239:686-92. 2006
    ..To prospectively evaluate the diagnostic performance of magnetic resonance (MR) spectroscopy in patients with suspicious lesions or biopsy-proved cancers at MR imaging by using histologic findings as the reference standard...
  38. ncbi The future of mammography: radiology residents' experiences, attitudes, and opinions
    Shrujal S Baxi
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    AJR Am J Roentgenol 194:1680-6. 2010
    ..The objective of our study was to assess the experiences and preferences of radiology residents with respect to breast imaging...
  39. ncbi Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision
    Melissa P Murray
    Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 119:1073-9. 2013
    ..Here, the authors report findings from 72 consecutive lesions with LN at CNB and prospective surgical excision (EXB)...
  40. ncbi Breast MRI screening of women with a personal history of breast cancer
    Sandra Brennan
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    AJR Am J Roentgenol 195:510-6. 2010
    ..The purpose of this article is to determine the cancer detection and biopsy rate among women who have breast MRI screening solely on the basis of a personal history of breast cancer...
  41. ncbi Cancellation of MR imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up
    Sandra B Brennan
    Department of Radiology, Breast Imaging Section, Memorial Sloan Kettering Cancer Center, Evelyn H Lauder Breast Center, New York, NY 10065, USA
    Radiology 261:92-9. 2011
    ..To determine the rate of canceled magnetic resonance (MR) imaging-guided breast biopsies due to nonvisualization of the lesion and to assess associated features and outcome data for these cases...
  42. ncbi Geographic access and the use of screening mammography
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Med Care 48:349-56. 2010
    ..Inadequate mammography resources in some areas may impair access to this technology. We assessed the relationship between availability of mammography machines and the use of screening...
  43. ncbi Malignant lesion segmentation in contrast-enhanced breast MR images based on the marker-controlled watershed
    YunFeng Cui
    Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA
    Med Phys 36:4359-69. 2009
    ..3% +/- 10.4%. Preliminary results suggest that the proposed algorithm is a promising method for assisting in tumor volume measurement in contrast-enhanced breast MRI...
  44. ncbi Impact of tamoxifen on amount of fibroglandular tissue, background parenchymal enhancement, and cysts on breast magnetic resonance imaging
    Valencia King
    Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Breast J 18:527-34. 2012
    ..A significant association exists between treatment with tamoxifen and decreases in BPE, cysts, and FGT on breast MRI...
  45. ncbi Breast imaging fellowships in the United States: who, what, and where?
    Shrujal S Baxi
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    AJR Am J Roentgenol 192:403-7. 2009
    ..CONCLUSION: A comprehensive list of fellowship training opportunities in breast imaging may help potential applicants identify relevant programs...
  46. ncbi 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography scanning affects surgical management in selected patients with high-risk, operable breast carcinoma
    Elisa Rush Port
    Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York, 10021, USA
    Ann Surg Oncol 13:677-84. 2006
    ....
  47. ncbi Style guidelines for radiology reporting: a manner of speaking
    Fergus V Coakley
    Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    AJR Am J Roentgenol 180:327-8. 2003
  48. ncbi Stereotactic 11-gauge vacuum-assisted breast biopsy: a validation study
    Georg Pfarl
    Department of Radiology, University of Vienna Medical School, AKH Wien, Waehringer Guertel 18-20, A-1090 Vienna, Austria
    AJR Am J Roentgenol 179:1503-7. 2002
    ..3% that diminished to 0.6% with experience. All false-negative findings could be prospectively identified because of failure to sample calcifications or imaging-histologic discordance...
  49. ncbi Lymphoscintigraphy for lymphatic mapping in breast carcinoma
    Laura Liberman
    Radiology 228:313-5. 2003
  50. ncbi Breast cancer in limited-resource countries: diagnosis and pathology
    Roman Shyyan
    Lviv Cancer Center, Lviv, Ukraine
    Breast J 12:S27-37. 2006
    ..Several approaches were again proposed for improving breast pathology, including training pathologists, establishing pathology services in centralized facilities, and organizing international pathology services...
  51. ncbi US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases
    Gerd Schueller
    Department of Radiology and Pathology, Medical University of Vienna, Waehringer Guertel 18 20, A 1090 Vienna, Austria
    Radiology 248:406-13. 2008
    ....
  52. ncbi Breast cancer screening with MRI--what are the data for patients at high risk?
    Laura Liberman
    N Engl J Med 351:497-500. 2004